WASHINGTON (AP) — The company behind a global recall of sleep apnea machines said Monday it will stop selling the devices in the U.S., under a tentative agreement with regulators that could cost the ...

Add Yahoo as a preferred source to see more of our stories on Google. The Philips Center is seen on Jan. 27, 2015, in Amsterdam, Netherlands. Philips, the company behind a global recall of sleep apnea ...

Sleep apnea is a common sleep disorder that affects more than 20 percent of people in the United States. It happens when your breathing temporarily stops while you sleep. Depending on the severity of ...

An estimated 1 billion people between the ages of 30 and 69 across the globe suffer from sleep apnea, particularly obstructive sleep apnea, according to a 2019 study. To treat sleep apnea, healthcare ...

(RTTNews) - Philips Respironics (PHGFF.PK, PHG) announced on Monday that on settling with the Food and Drug Administration, it has decided to halt the sales of the company's ventilators and CPAP ...

Add Yahoo as a preferred source to see more of our stories on Google. Philips said Monday it will stop selling its sleep apnea machines in the US, more than two years after the Dutch manufacturer ...

The company behind a global recall of sleep apnea machines said Monday it will stop selling the devices in the U.S., under a tentative agreement with regulators that could cost the manufacturer nearly ...

This article originally appeared on ProPublica. ProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like this one in your inbox.

HERE’S INVESTIGATIVE REPORTER PAUL VAN OSDOL. THE RECALL AFFECTED MILLIONS OF BREATHING MACHINES MADE BY PHILIPS, WHICH HAS OFFICES HERE IN BAKERY SQUARE AND IN MORRISVILLE. ON SATURDAY, DON SCHREIBER ...

The move comes as Philips has agreed to a consent decree with the Food and Drug Administration and the Department of Justice that could cost the company nearly $400 million. In June 2021, Philips ...